| News

Lonza manufactures coronavirus vaccine for Moderna

17.11.2020

Lonza plans to start production of Moderna’s coronavirus vaccine in Switzerland before the end of the year. Moderna published the initial results from a phase 3 study, according to which the vaccine candidate is 94.5 percent effective. Moderna opened a subsidiary in Basel to drive forward the production of the vaccine from there.

Moderna is a vaccine manufacturer working on a COVID-19 vaccine. Based in Massachusetts, the manufacturer has founded a subsidiary in Basel. According to Basel Area Business & Innovation in August, Moderna was “vigorously supported” when setting up the new company, Moderna Switzerland GmbH. The support ranged from questions on setting up a company and work permits with regard to the COVID-19 situation to suggestions about office spaces. The successful establishment of a subsidiary by Moderna will highlight the attractiveness of the Basel area’s biotech ecosystem.

Lonza will manufacture the mRNA-1273 vaccine for Moderna. According to a press release from the Basel-based pharmaceutical supplier, large-scale production started at its American factory in Portsmouth, NH at the end of September. Production is also set to start at Lonza’s factory in Visp in the canton of Wallis before the end of the year. Lonza plans to manufacture 400 million vaccine doses per year at Visp. Back in May, Moderna and Lonza agreed on a total manufacturing output of 1 billion doses per year.

Moderna has recently published the initial results from a phase 3 study, according to which the vaccine candidate is 94.5 percent effective.

Lonza is also working on the development of a coronavirus vaccine with another American manufacturer: Humanigen. Cameron Durrant, CEO of Humanigen, is quoted in a press release on the collaboration, saying: “This collaboration with Lonza, a global manufacturing leader with expertise in technology transfer and an established track record of working with regulatory bodies for approved and commercialized products, comes at a crucial time to meet production demand for COVID-19 therapeutics this winter.”

Share this article

Sign up to receive our newsletter in your inbox.

You may also be interested in

Meteoblue constantly presents new developments
Basel Area Business & Innovation, Innovation, Invest

Meteoblue constantly presents new developments

The meteoblue weather service based in Basel has developed a weather map widget that can be embedded in any website....

Read More
Lonza manufactures coronavirus vaccine for Moderna
Basel Area Business & Innovation, Innovation, Invest

Lonza manufactures coronavirus vaccine for Moderna

Lonza plans to start production of Moderna’s coronavirus vaccine in Switzerland before the end of the year. Moderna published the...

Read More
Synendos raises 20 million Swiss francs
Basel Area Business & Innovation, Innovation, Invest

Synendos raises 20 million Swiss francs

Synendos Therapeutics has concluded a Series A financing round, raising 20 million Swiss francs. The Basel biotech will use the...

Read More
ChemAxon establishes subsidiary in Basel
Basel Area Business & Innovation, Innovation, Invest

ChemAxon establishes subsidiary in Basel

ChemAxon develops software for application in the chemicals and biopharma industries. Now, the Hungarian company has established a subsidiary in...

Read More
DSM strengthens the Basel Area life sciences cluster
Basel Area Business & Innovation, Innovation, Invest

DSM strengthens the Basel Area life sciences cluster

The global nutrition and health corporation Royal DSM is establishing a new innovation center at the headquarters of Nutritional Products...

Read More
Canton of Jura looking towards robotics
Basel Area Business & Innovation, Entrepreneurship, Healthcare Innovation, Industrial Transformation, Invest, Switzerland Innovation Park

Canton of Jura looking towards robotics

The canton of Jura has for quite some time been a hub for the precision industry. Now, however, companies such...

Read More
1 2 3 4

Do you have a question? We'd like to hear from you.